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Abstract: Background: In 2017, Mbeya Zonal Referral Hospital (MZRH) and the University of
South Carolina (UofSC) agreed to collaboratively strengthen antimicrobial prescribing in the southern
highlands of Tanzania and train a new generation of clinicians in responsible antimicrobial use. Methods:
Key stakeholders and participants were identified and the Mbeya Antimicrobial Stewardship Team
(MAST) was created. The team identified assets brought by the collaborators, and four investigations
of baseline needs were developed. These investigations included (a) a baseline clinician survey
regarding antimicrobial resistance and stewardship, (b) a serial chart review of inpatient antimicrobial
prescribing practices, (c) an investigation of antimicrobial resistance rates using existing isolates at the
MZRH laboratory, and (d) a survey of antimicrobial availability at community pharmacies in the city.
Results: 91% of physicians believe antimicrobial resistance is problem in Tanzania, although only 29%
of physicians were familiar with the term “antimicrobial stewardship”. Escherichia coli isolates had
resistance rates of over 60% to the commonly used agents ciprofloxacin, trimethoprim-sulfamethoxazole,
and ceftriaxone. Thirteen out of 14 community pharmacies offered over-the-counter antibiotics for
upper respiratory symptoms. Conclusions: International antimicrobial stewardship collaborations
can successfully identify opportunities and needs. Evaluating the team’s efforts to improve patient
outcomes will be essential.
Keywords: antimicrobial stewardship; antimicrobial resistance; Low to Middle Income Countries
(LMIC); East Africa; Tanzania; global health

1. Introduction
Low and middle-income countries (LMICs) shoulder a disproportionate share of many global
health problems, including antimicrobial resistance (AMR) [1]. Many LMICs have high rates of routine
antibiotic use without a prescription or clinician oversight, and clinicians in all countries often prescribe
antibiotics unnecessarily [2]. This problem of antibiotic overuse and the associated specter of rising
AMR led the World Health Organization (WHO) to publish a Global Action Plan on Antimicrobial
Resistance in 2015 [1,3].
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Institutions that have successfully implemented programs to curb inappropriate antimicrobial
prescribing have done so through interdisciplinary clinician education, protocol development,
and ongoing reviews of guideline adherence [4,5]. Establishment of these antimicrobial stewardship
(AMS) interventions has been developed in multiple LMICs [6–10]. Specifically in African nations,
AMS implementation has been limited but successful in several published reports, although these
programs have additional challenges [11–20]. A recent global call for collaborative stewardship efforts
was made to develop programmatic AMS across LMICs [21].
The University of South Carolina (UofSC) and the Mbeya Zonal Referral Hospital (MZRH) have
had collaborative educational programs since 2012. In August 2017, at an on-site visit at MZRH, several
staff of these two institutions discussed the creation of an AMS program at MZRH using experiences
from the established stewardship program at UofSC and Prisma Health Midlands, the partnering
hospital system in Columbia, South Carolina, USA. This article discusses the development of this
program, initial results, and lessons learned.
2. Materials and Methods
2.1. Partnership Development: Asset Mapping
MZRH is the tertiary referral site for a population of over eight million people, 16% of the country’s
population, living in the Southern Highlands Zone of Tanzania [22]. AMR was a preexisting concern
of hospital leadership at MZRH, and they actively sought a partnership to work on the problem
collaboratively. As a tertiary care center associated with a medical school, it is well suited to implement
projects that influence care throughout the region. The hospital’s director of Research and Education is
a microbiologist by training and had collected two years of culture data for review and compilation.
In addition, the MZRH laboratory had large climate-controlled freezers containing an inventory of many
blood and urine isolates from previous years, making them available for further testing. The Prisma
Health Midlands, affiliated hospital system of UofSC, stewardship program has been recognized as
an Infectious Diseases Society of America (IDSA) Center of Excellence since 2019 [23]. Additionally,
the UofSC hosts an infectious diseases pharmacy residency and clinical fellowship program that has
significant experience in AMS both in hospital and community settings [24]. The program facilitates a
global health experience with MZRH for 4–8 weeks annually. Finally, the UofSC Department of Family
and Preventive medicine hosts a Global Health fellowship that allows a clinical faculty member up to
6 months living in Mbeya over two years to facilitate collaborations between the two institutions [25].
UofSC and MZRH have had collaborative projects through this program since 2012.
2.2. Partnership Development: Needs Assessment
Tanzania is known to have high rates of ESBL-producing Enterobacteriaceae and beta-lactam
resistant Streptococcus pneumoniae [26–28]. However, no known study has focused on AMR rates in
the Mbeya region. There are reasons to suspect an altered AMR pattern in the Southern Highlands
region of Tanzania; it borders two neighboring countries with relatively high cross-border traffic, and it
also has some of the highest rates of HIV in the nation [29]. As for antimicrobial use in the region,
there had never been a systematic investigation of antibiotic prescribing at the hospital or community
levels in Mbeya. Several of the authors noted anecdotally that MZRH wrestles with issues common
to many LMICs, including medication access difficulties, lack of local guidelines, and inconsistently
performed diagnostics.
2.3. Creation of the Antimicrobial Stewardship Team
After recognizing the mutual interest in strengthening AMS efforts at MZRH and identifying the
assets shared between the two institutions, a partnership was agreed upon to develop an AMS team,
including representatives from MZRH pharmacy, nursing, physician and administrative departments,
along with pharmacy and physician members from UofSC. This group was titled the Mbeya Zonal
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and a survey of over-the-counter availability of antibiotics at local pharmacies. Refer to Figure 2 for a
timeline of implementation activities.
•

Baseline Clinician Survey: A 16-question clinical survey regarding local AMR patterns and AMS
concepts was administered to MZRH clinicians of all cadres in the departments of Internal Medicine
and Pediatrics. The survey assessed clinicians’ awareness of local AMR patterns, confidence in
making empirical antibiotic treatment decisions, perceived barriers to MZRH patients receiving
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optimal antibiotic therapy, and familiarity with the concept of AMS. Of the 16 questions, 12 were
based on a 5-point Likert scale. Two were single-answer multiple choice, and 1 was a multiple
choice in which more than one answer could be selected. One additional question was a ranking
question in which respondents were asked to rank items in order from 1 through 6, with 1 being
the most important factor and 6 being the least. The survey was anonymous, but respondents
were asked to provide their designations (“intern”, “registrar”, “specialist”, etc.)
Chart Review of Antimicrobial Prescribing Practices: A retrospective chart review assessed
baseline inpatient antibiotic utilization patterns at MZRH. Beginning with 1 January 2018,
the authors chronologically reviewed all adult inpatient medical records for the MZRH adult male
and female medical wards until 100 charts involving antibiotic therapy were included. Data points
collected included antibiotic-specific metrics, including antibiotic name, indication, days of
therapy prescribed, and days of therapy administered. Other data points collected included
patient demographics, infection-pertinent comorbidities, length of stay, 30-day readmission,
in-house mortality, payer status, and culture utilization. Additional calculated metrics included
frequency of antibiotic course completion, antibiotic use per infectious indication, and concordance
with national antibiotic guidelines, specifically the Tanzania Standard Treatment Guidelines and
National Essential Medicines List, 5th edition [30]. A detailed description of the methods for this
investigation is published elsewhere [22].
Local Antimicrobial Resistance Patterns: To assess AMR patterns, the MAST evaluated MZRH
culture and resistance data, as cataloged by the MZRH microbiology department over 2 years prior
to this study’s initiation. Cultures included specimens from multiple body sites. All of the positive
cultures were speciated using manual techniques, and antibiotic susceptibility was determined
using Kirby–Bauer (KB) disk diffusion method. To ensure reliability of the KB methodology,
a microbiologist randomly selected 25 Enterobacteriaceae isolates (comprising Escherichia coli and
Klebsiella species) and performed a second independent evaluation of resistance to these agents
using E-tests.
Community pharmacy survey: Finally, we surveyed local pharmacies in the city of Mbeya to
assess the availability of antibiotics without a prescription (“over-the-counter”). Two teams of
2 authors each presented to 15 different local Mbeya pharmacies complaining of nonspecific upper
respiratory symptoms. The pharmacy name, location, designation of the pharmacy employee
Pharmacy 2020, 8, x FOR PEER REVIEW
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•

Baseline Clinician Survey: A 16-question clinical survey regarding local AMR patterns and
AMS concepts was administered to MZRH clinicians of all cadres in the departments of Internal
Medicine and Pediatrics. The survey assessed clinicians’ awareness of local AMR patterns,
confidence in making empirical antibiotic treatment decisions, perceived barriers to MZRH
patients receiving optimal antibiotic therapy, and familiarity with the concept of AMS. Of the 16
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3. Results
3.1. Baseline Clinician Survey
There were 45 respondents to the baseline clinician survey, and 78% have been in practice for
≤5 years. Overall, 91% of respondents feel that AMR is a problem nationally, while 82% believe it is also
a problem locally at MZRH. In contrast, over 30% of respondents were not aware of AMR patterns either
nationally or locally. The overwhelming majority of respondents were confident in their ability to select
appropriate empirical and definitive antibiotic choices, interpret microbiology results, and discuss or
teach antibiotic therapy with a patient or colleague, respectively. Most respondents (78%) reported
they use published guidelines to aid in empirical antibiotic decisions, while only 8% use peer-reviewed
primary literature. Only 29% were familiar with the term “antimicrobial stewardship”. Full results are
available in Table 1. Due to the relatively small numbers in the survey, we did not perform statistical
calculations based on clinician subgroupings. However, more experienced clinicians did generally
report greater familiarity with AMS concepts. For example, 6 out of 7 attending physicians indicated
they were familiar with the term “Antimicrobial Stewardship”, while only 7 of 38 clinicians at earlier
stages of their career responded in that way.
Table 1. Baseline Clinician Survey Results *.
Question

1

2

3

4

5

Q1: I believe antibiotic resistance is a problem
nationally in Tanzania.

4.5%

2.3%

2.3%

36.4%

54.5%

Q2: I believe antibiotic resistance is a problem
locally at Mbeya Zonal Hospital.

9.1%

2.3%

6.8%

52.3%

29.5%

Q5: I believe my patients receive antibiotics in
a timely fashion following suspected or
confirmed infectious diagnoses.

6.7%

15.6%

15.6%

33.3%

28.9%

Q6: I am confident in my ability to select
appropriate empirical antibiotic therapy based
on a given diagnosis.

2.2%

4.4%

6.7%

33.3%

53.5%

Q7: I am confident in my ability to accurately
interpret culture and susceptibility reports.

0.0%

2.3%

4.5%

18.2%

75.0%

Q8: I am confident in my ability to determine
appropriate definitive antibiotic therapy
based on available diagnostic reports.

0.0%

2.2%

2.2%

33.3%

62.2%

Q9: I am confident in my ability to discuss
antibiotic therapy with a patient.

2.2%

2.2%

8.9%

37.8%

48.9%

Q10: I am confident in my ability to discuss or
teach antibiotic therapy principles to a peer.

4.4%

0.0%

8.9%

31.1%

55.6%

Q11: I am aware of antibiotic resistance
patterns nationally.

8.9%

13.3%

13.3%

46.7%

17.8%

Q12: I am aware of antibiotic resistance
patterns at Mbeya Zonal Hospital.

17.8%

8.9%

13.3%

51.1%

8.9%

Q13: I am familiar with the term antimicrobial
stewardship.

31.8%

15.9%

22.7%

13.6%

15.9%

Q14: I am familiar with the approximate costs
of commonly used antibiotics that
hospitalized patients are prescribed.

6.7%

8.9%

13.3%

55.6%

15.6%

* Not all respondents answered every question. Due to rounding, percentages may not add up to exactly 100%.
5 = Strongly Agree; 4 = Somewhat Agree; 3 = Neutral; 2 = Somewhat Disagree; 1 = Strongly Disagree. Bold number:
the most frequent response.
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Table 2. Antimicrobials provided by community pharmacies for upper-respiratory tract infection symptoms.

Table 2. Antimicrobials provided by community pharmacies for upper-respiratory tract infection
Pharmacy Number
Antibiotic Regimen
Cost (TSH)
symptoms.
1
Amoxicillin 500 mg 3× daily × 3 days
2000
2 Number
Azithromycin
500 mg
daily × 3 days
2550
Pharmacy
Antibiotic
Regimen
Cost
(TSH)
3
Ampicillin/cloxacillin 250/250 mg 3× daily × 5 days
2000
4
Azithromycin 500 mg daily × 3 days
16,400
5
Sulfamethoxazole/Trimethoprim 2 SS tablets 2× daily × 7 days
3000
6
Amoxicillin/Clavulanate 625 mg 2× daily × 7 days
32,000
7
Amoxicillin 500 mg 3× daily × 5 days
30,000
8
Ampicillin/Cloxacillin 250/250 mg 3× daily × 5 days
3000
9
Cephalexin 250 mg 2 tablets 3× daily × 5 days
4000
10
Erythromycin 250 mg 2 tablets 3 × 5 days
3000
11
Lomefloxacin daily × 5 days
3000
12
Cefpodoxime 100 mg 2× daily × 5 days
25,000
13
Cefuroxime 250 mg BID × 5 days
18,000
14
None Offered
N/A

4. MAST: Analysis to Implementation
Antimicrobial Guidebook
Armed with information on local AMR patterns, local prescribing patterns, and clinician
perceptions on AMS, the MAST believed this data could inform a local guide to complement the
Tanzanian national guidelines for empirical therapy. These guidelines are widely available and
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offer recommendations for empirical therapy based on suspected or proven source of infection [30].
However, these guidelines do not fully account for variable patient populations, local resistance
patterns, or local medication supply chains. The MAST believed that some of these difficulties could
contribute to the relatively low adherence of empiric antimicrobial regimens to the national guidelines
and frequently inappropriate truncations of therapy while in the hospital. Additionally, the MAST felt
that a brief local guidebook could be made available through electronic media (e.g., WhatsApp™) to
all house staff and to improve uptake by the medical staff. This particular electronic platform was
used to distribute the guidebook because it is already widely available among the clinicians of MZRH
on their personal devices. It does, however, require the clinicians to use their personal data plan
to download the document. The MZRH Antibiotic Guidebook 1st edition would focus on the most
common bacterial infectious diseases encountered. Diseases such as malaria, HIV, or tuberculosis,
while common, were considered to be outside the scope of the guidebook. The final list of disease
states included skin and soft tissue infections, cystitis, pyelonephritis, meningoencephalitis, bacterial
pneumonia, enteritis/colitis. A special section on general management of sepsis was added upon request.
Decisions regarding empirical drug choice weighed each of the following: known local resistance
patterns, consistency of drug availability, national guideline recommendations, other evidence-based
recommendations,
Pharmacy 2020, 8, x FOR and
PEERclinician
REVIEW experience (Figure 5, cover of guidebook only; full guidebook
9 of is
14
available upon request).

Figure 5. Cover of the Mbeya Zonal Referral Hospital Adult Antimicrobial Guidebook 2018 (1st edition).
[Note: Full guidebook available upon request].

Figure 5. Cover of the Mbeya Zonal Referral Hospital Adult Antimicrobial Guidebook 2018 (1st

Once
theNote:
MZRH
guidebook
was complete and approved by the MAST, the MZRH
edition).
Fullantimicrobial
guidebook available
upon request].
hospital administration and medical staff, it was promoted among all MZRH clinical staff as a
hospital
standard-of-care.
The MAST
first presented
the guidebook
to MZRH
registrars,
Once
the MZRH antimicrobial
guidebook
was complete
and approved
by the interns,
MAST, the
MZRH
and
attending
physicians
at
morning
report
for
the
departments
of
internal
medicine,
pediatrics,
hospital administration and medical staff, it was promoted among all MZRH clinical staff as a
and
obstetrics/gynecology
(OBGYN).
Subsequently,
presented
the guidebook
again to and
the
hospital
standard-of-care. The
MAST first
presented thewe
guidebook
to MZRH
interns, registrars,
hospital-wide
medical
staff
at
MZRH’s
weekly
staff
education
meeting.
The
guidebook
was
also
attending physicians at morning report for the departments of internal medicine, pediatrics, and
emphasized
by several(OBGYN).
authors onSubsequently,
daily internal we
medicine
teaching
rounds, where
to
obstetrics/gynecology
presented
the guidebook
againitstoapplication
the hospitalpatient
care was
demonstrated
at the bedside.
An electronic
copy
the guidebook
wasemphasized
distributed
wide medical
staff
at MZRH’s weekly
staff education
meeting.
Theofguidebook
was also

by several authors on daily internal medicine teaching rounds, where its application to patient care
was demonstrated at the bedside. An electronic copy of the guidebook was distributed to all MZRH
interns and registrars in PDF format via WhatsApp™ Messenger. Paper copies of the guidebook were
posted at the nurses’ station of each MZRH ward, and available nurses and students of all types were
educated on the guidebook’s utility at that time.
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to all MZRH interns and registrars in PDF format via WhatsApp™ Messenger. Paper copies of the
guidebook were posted at the nurses’ station of each MZRH ward, and available nurses and students
of all types were educated on the guidebook’s utility at that time.
Over the next several months, the authors evaluated uptake and usage of the guidebook
at MZRH via several methods. First, certain MZRH interns and registrars were designated as
key respondents, and the authors inquired about ongoing guidebook utilization through regular
text message communications with these clinicians. Next, regular videoconferences were held
between UofSC clinicians and the MAST to discuss current guidebook utilization and future
promotional activities.
5. Discussion
As has been detailed above the MZRH and UofSC partnership has been a fruitful endeavor over
the past several years. Here we will attempt to synthesize the results from our initial projects as well as
review successful strategies, lessons learned and remaining challenges.
5.1. Discussion of Results
While the term “Antimicrobial Stewardship” is not widely known by junior Tanzanian physicians,
the problem of AMR is clearly recognized. There was therefore little need to persuade the new house
staff about the need for responsible antimicrobial therapy. It was perhaps surprising, however, to note
how empirical treatment infrequently fully aligned with national guidelines. While nearly two-thirds
of patients were initiated on the recommended agents, only 15% were able to complete the required
therapy [31]. Empirical recommendations and durations are of paramount importance, because in our
chart review of inpatient prescribing, only 15% of patients had diagnostic testing. Diagnostic testing
will often be considered an unaffordable luxury as long as financial resources remain scarce at MZRH.
In the meantime, ensuring patients reliably receive appropriate durations of appropriate antimicrobials
should improve outcomes.
We expected to find a degree of AMR in the isolates available at the MZRH lab but did not expect
such substantial resistance to trimethoprim/sulfamethoxaxole. This could be the result of widespread
availability of antibiotics in the community, Pneumocystis jirovecii prophylaxis in the HIV-infected
population, or the historical use of sulfa-based antimalarials. This finding demonstrates the need
for local AMR data to guide the empirical recommendations. However, the significant discordance
between KB and E-test methodologies for certain antimicrobial susceptibilities in the MZRH sample of
isolates highlights some difficulties in obtaining reliable resistance data in LMIC settings.
5.2. Successful Strategies
One dominant theme in productive global health work is to work in a spirit of collaboration and
partnership, rather than of one-sided mentorship. This program was built on 5 years of the existing
partnership between our institutions with the strong interest of local leadership in AMS guiding project
development. All aspects of the project were performed in collaboration with careful thought and
consideration of local and national standards of care and local resource availability. A broad level of
support across each institution proved very helpful in developing the multi-modal evaluations needed
to start an AMS effort in Southern Tanzania. We felt we were better able to inform our investigations and
tailor our interventions to the local situations because we had input from a wide range of colleagues.
Having multiple supporting collaborators across the organizations has been critical, but this project
has required a specific champion at each institution to keep the project moving forward. The local
champions have been the ones responsible for organizing meetings, setting agendas, and following up
on individual tasks. Without an individual taking responsibility for shepherding the team, projects
and team meetings would stumble.
Within a spirit of broad-based partnership, some successes came by not only assessing needs
and identifying gaps in care, but also recognizing institutional strengths and resources. For example,
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by using existing MZRH data and isolates already collected, we were able to reach conclusions about
local resistance much more quickly and economically than if dependent on prospective collection
alone. From the UofSC side, contributing the time and expertise of our Global Health Fellow provided
the program with a dedicated collaborator who could spend time in both sites and initiate projects.
Incorporating a global rotation into the Infectious Diseases pharmacy residents’ academic schedule
also allowed these pharmacists time to substantially contribute to the program. Building from existing
institutional strengths has helped to keep costs low as no external funding was used for the initiation
of this program. The lack of dependence on external grant funding to start up the AMS collaboration
should bode well for its sustainability.
Another practical strategy is the use of virtual means to conduct meetings and write protocols and
papers collaboratively across time zones. Travel back and forth between South Carolina and Mbeya is
time consuming and costly. A collaborative stewardship team requires a relatively small increments
of time invested over a longer period. Recurring international in-person meetings are not possible,
but recurring virtual meetings are much more plausible.
While our overarching long-term goal has been to improve patient outcomes through improved
antimicrobial stewardship, short-term victories have also been encouraging to those involved. All US
and Tanzanian partners grew through this process in terms of international collaboration, academic
leadership, and research and publication experience.
5.3. Lessons Learned
As with any partnership, several challenges remain from practical human issues to larger scale
economic and systemic concerns. Travel to Tanzania or South Carolina by respective institutions is
limited to once or twice a year for this reason. Having existing personal relationships from prior
projects has been an important foundation in building the program. When the program was first
introduced, extensive time and resources were required from both institutions for implementation
and education. Continued education to the new health care staff at MZRH has relied heavily on
daily rounds by MZRH program partners and annual visits from UofSC partners. Local investment
in this collaboration has become more important for providing continual education and sustaining
the program.
Thus, more frequent teleconferences and video meetings with MAST and UofSC were implemented
to assist with continued education and problem-solving any barriers that were presenting themselves
throughout the month. Virtual meetings have been an essential component to this program, despite
they too have significant practical challenges. The very clinicians and pharmacists that are best suited
to provide “on the ground” insight at the meetings are also those most likely to be called away to other
duties. Differing time zones and clinical schedules add additional complexity to arranging meetings
without infringing on other responsibilities. We have found that most work happens asynchronously
through email or other means, with organized video or in-person meetings relatively rare and focused
on relationship building and items that require real-time discussion.
Academic development has been a real strength of our collaboration, although funding for
collaborators for presenting findings at scientific meetings has been limited to what host institutions
have been able to provide within routine budgets. Since LMICs run on smaller budgets, they have had
fewer opportunities to present their ideas to a wider audience.
Working in resource-limited environments presents ethical challenges when an ideal local,
affordable, and available treatment may not always be possible. The MAST team cannot solve these
economic realities independently, but by collecting and publishing data on resistance rates, we feel we
provide an avenue to advocate for access on the national level. A short-term strategy could include
dual guidelines that include both optimal treatments along with more affordable, albeit suboptimal
options. Such dual guidelines may be very practical but are a very sensitive topic in that they expose
disparities in care.
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5.4. Future Directions
MZRH is a teaching hospital, with a new cohort of clinicians arriving every year. This is a
great opportunity to influence a new generation of physicians on responsible antimicrobial use, but it
comes with the great challenge of educating a new group every single year. Building a culture of
responsible antimicrobial use is not a process that will be completed in two years. The antimicrobial
guidebook is an exciting new step, although its effectiveness to alter prescribing habits or improve
patient outcomes remains to be seen. Most institutions that have seen demonstrable changes in these
indicators did release institution specific guidelines, but also had more effective real-time tracking
mechanisms and more rigorous ways to encourage change. There are plans to investigate the impact
of initial strategies on guideline compliance and to develop and implement additional interventional
stewardship activities, such as prospective audit and feedback.
Sustainability of the program requires the use of readily available data to drive decisions making.
One data point commonly used in the field of AMS is antimicrobial consumption data. Variability in
supply and variability in sources of antibiotics at MZRH has meant that, so far, no reliable and easily
repeatable estimate of antimicrobial consumption at the hospital has been identified. Without such
large-scale assessments, prescribing habits require serial chart reviews, which are labor-intensive and
time-consuming. Developing a low-cost, high-fidelity mechanism to assess habits will be integral to
the success of the program.
One ideal method to increase AMS sustainability and timeliness of intervention uptake is to develop
a more formal AMS training program in partnership between the two collaborating institutions. A very
important aspect of this success would be the ability to bring MZRH colleagues to the United States to
experience AMS at UofSC and Prisma Health Midlands. This strategy has been successfully utilized
by others [34]. Facilitating collaborations with similar groups in East Africa or other LMICs would
also bring new insights into addressing the practical problems of AMS in these regions [20].
6. Conclusions
The partnership between the MAST and the UofSC has had some real successes. It has helped
introduce the concept of AMS to a new generation of learners in East Africa. It has also provided
some specific data on prescribing habits in the region, availability of antimicrobials in the community,
and illustrations of difficulties with adhering to guidelines in an economically constrained region.
The partnership has also been successful in cultivating academic productivity in newer clinical faculty
with limited prior experience in disseminating research, and it has helped provide a platform for the
exchange of ideas and experiences between institutions.
The work is still challenging. Inappropriate use of antibiotics is a stubborn problem throughout
the world, and this remains true at both of our institutions. Clearly, such partnerships remain critical.
Antimicrobial resistance will inevitably become an increasing problem in LMICs as antimicrobials
become more available in these regions. Developing strong AMS teams at teaching hospitals across the
globe is a critical strategy to address this problem in the coming years.
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